🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

Judge blocks South Dakota rule that hinders medication abortions

Published 01/26/2022, 10:47 PM
Updated 01/26/2022, 10:51 PM
© Reuters. FILE PHOTO: Supporters of Planned Parenthood Ohio chant at a pro-choice rally as the United States Supreme Court justices hear arguments in the Mississippi abortion rights case Dobbs v. Jackson Women's Health, in Cincinatti, Ohio, U.S., December 1, 2021.

(Reuters) - A federal judge in South Dakota temporarily blocked on Wednesday a new rule by the state's health department that makes access to a medication abortion more difficult.

Planned Parenthood sought the injunction against the South Dakota measure, which was first part of an executive order issued last September by Governor Kristi Noem, a Republican.

Judge Karen Schreier wrote in her ruling that Planned Parenthood had shown that South Dakota had created a "substantial obstacle" in the path of women seeking medication abortions.

Noem's executive order mandated that the two drugs used in mediation abortions both be administered by a medical provider. Typically, a woman would receive the first medication at a provider's office, and be handed the second drug at the same time, with instructions to take it 24 to 72 hours later.

Because Planned Parenthood's office in Sioux Falls is the only one that provides abortions in the state, and because many women travel long distances to reach its office, forcing them to make repeat visits could put an undue burden on many women, the judge wrote in her restraining order.

The legal battle over abortion in the United States has grown increasingly tense in recent months. In December, the Supreme Court, with a 6-3 conservative majority, heard arguments in Mississippi's bid to revive its 15-week ban on abortions.

© Reuters. FILE PHOTO: Supporters of Planned Parenthood Ohio chant at a pro-choice rally as the United States Supreme Court justices hear arguments in the Mississippi abortion rights case Dobbs v. Jackson Women's Health, in Cincinatti, Ohio, U.S., December 1, 2021. REUTERS/Megan Jelinger

Conservative justices indicated then that they are open to either gutting or overturning entirely Roe v. Wade, the 1973 case that established a woman's right to terminate her pregnancy before the fetus is viable. A decision is due by the end of June.

In December, the federal government permanently eased some restrictions on medication used in abortions for up to 10 weeks of pregnancy, allowing the drug to be sent by mail rather than requiring it to be dispensed in person. However, 19 states have laws that supersede the FDA decision by barring telehealth consultations or mailing of abortion pills.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.